
Certis Oncology Solutions: Precision-care provider for individualized patient care since 2016.
Certis Oncology Solutions, founded in 2016, is dedicated to providing individualized precision patient care. The company focuses on developing advanced oncology solutions that cater to the specific needs of each patient. They offer a range of services designed for drug developers and oncologists, aiming to enhance the effectiveness of cancer treatments through personalized approaches. Certis Oncology Solutions leverages cutting-edge technology and scientific research to deliver tailored therapeutic strategies, positioning itself at the forefront of precision oncology.
Notable figures affiliated with Certis Oncology Solutions include leading experts in oncology and precision medicine, although specific names are not provided. The company has achieved significant milestones in improving patient outcomes through its innovative solutions. By collaborating with drug developers and oncologists, Certis has made a substantial impact on the field of cancer treatment, contributing to the advancement of personalized medicine and setting new standards in patient care.

OncoPrecision
oncoprecision.bio

Onc.AI
onc.ai

Onko Solutions

Strata Oncology
strataoncology.com

GenomOncology
genomoncology.com

xCures
xcures.com

Precision Health AI

Predictive Oncology

OncoTartis

CerFlux
cerflux.com

Oncobox
oncobox.com

Oncora Medical
oncoramedical.com

OncXerna Therapeutics
oncxerna.com

OncoResponse

OncoHealth
oncohealth.us
Companies similar to Certis Oncology Solutions include OncoPrecision, Onc.AI, Onko Solutions and Strata Oncology.
Certis Oncology Solutions was founded in 2016.
Certis Oncology Solutions' headquarters is located in San Diego, CA, US.
Certis Oncology Solutions' most recent funding round was for $10M (USD) in January 2024.
As of Jan 1, 2024, Certis Oncology Solutions has raised a total of $10M (USD).
Certis Oncology Solutions has 74 employees as of Feb 5, 2024.